161 related articles for article (PubMed ID: 28717722)
81. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
Wang Q; Fu J; Hu L; Fang F; Xie L; Chen H; He F; Wu T; Lawrie TA
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007289. PubMed ID: 28892119
[TBL] [Abstract][Full Text] [Related]
82. Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary.
Fülöp V; Szigetvŕi I; Szepesi J; Török M; Berkowitz RS
J Reprod Med; 2008 Jul; 53(7):541-6. PubMed ID: 18720931
[TBL] [Abstract][Full Text] [Related]
83. Serum human chorionic gonadotropin ratios for the detection of etoposide, methotrexate, dactinomycin, cyclophosphamide, and vincristine resistance in high-risk gestational trophoblastic neoplasia.
Sirimusika N; Boonyapipat S
Health Sci Rep; 2022 Jul; 5(4):e729. PubMed ID: 35873390
[TBL] [Abstract][Full Text] [Related]
84. Outcomes of Low-Intensity Treatment of Acute Lymphoblastic Leukemia at Butaro Cancer Center of Excellence in Rwanda.
Rubagumya F; Xu MJ; May L; Driscoll C; Uwizeye FR; Shyirambere C; Larrabee K; Fehr AE; Gilbert UD; Muhayimana C; Hategekimana V; Elmore S; Mpunga T; Moore M; Shulman LN; Lehmann L
J Glob Oncol; 2018 Sep; 4():1-11. PubMed ID: 30241148
[TBL] [Abstract][Full Text] [Related]
85. Management of drug resistant gestational trophoblastic neoplasia.
Patel SM; Desai A
J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
[TBL] [Abstract][Full Text] [Related]
86. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
Chen YX; Shen YM; Qian JH; Xie X
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
[TBL] [Abstract][Full Text] [Related]
87. Uterine Rescue in High-Risk Gestational Trophoblastic Neoplasia Treated with EMA-CO by Uterine Arteries Embolization due to Arteriovenous Malformations.
Silva ACBD; Passos JP; Signorini Filho RC; Braga A; Mattar R; Sun SY
Rev Bras Ginecol Obstet; 2021 Apr; 43(4):323-328. PubMed ID: 33979893
[TBL] [Abstract][Full Text] [Related]
88. Hepatic metastasis in gestational trophoblastic neoplasia: patient characteristics, prognostic factors, and outcomes.
Barber EL; Schink JC; Lurain JR
J Reprod Med; 2014; 59(5-6):199-203. PubMed ID: 24937957
[TBL] [Abstract][Full Text] [Related]
89. The roles of surgery and EMA/CO chemotherapy regimen in primary refractory and non-refractory gestational trophoblastic neoplasia.
Aydiner A; Keskin S; Berkman S; Bengisu E; Ilhan HR; Tas F; Topuz E
J Cancer Res Clin Oncol; 2012 Jun; 138(6):971-7. PubMed ID: 22358303
[TBL] [Abstract][Full Text] [Related]
90. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary.
Fülöp V; Szigetvári I; Szepesi J; Végh G; Bátorfi J; Nagymányoki Z; Török M; Berkowitz RS
J Reprod Med; 2010; 55(5-6):253-7. PubMed ID: 20626182
[TBL] [Abstract][Full Text] [Related]
91. Evaluation and influence of lung metastasis on patient outcome in gestational trophoblastic neoplasia: A 10-year study at a single institution.
Yu H; Li J; Zhu T; Xue X; Lu X
Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():162-166. PubMed ID: 32505789
[TBL] [Abstract][Full Text] [Related]
92. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
93. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Lurain JR; Nejad B
Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
[TBL] [Abstract][Full Text] [Related]
94. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
95. Methotrexate, bleomycin, and Etoposide in the treatment of gestational trophoblastic neoplasia.
Ngan HY; Tam KF; Lam KW; Chan KK
Obstet Gynecol; 2006 May; 107(5):1012-7. PubMed ID: 16648404
[TBL] [Abstract][Full Text] [Related]
96. Early prediction of post-molar gestational trophoblastic neoplasia and resistance to methotrexate, based on a single serum human chorionic gonadotropin measurement.
Hoeijmakers YM; Eysbouts YK; Massuger LFAG; Dandis R; Inthout J; van Trommel NE; Ottevanger PB; Thomas CMG; Sweep FCGJ
Gynecol Oncol; 2021 Dec; 163(3):531-537. PubMed ID: 34602288
[TBL] [Abstract][Full Text] [Related]
97. Combined methotrexate-dactinomycin: an effective therapy for low-risk gestational trophoblastic neoplasia.
Eiriksson L; Wells T; Steed H; Schepansky A; Capstick V; Hoskins P; Pike J; Swenerton K
Gynecol Oncol; 2012 Mar; 124(3):553-7. PubMed ID: 22079360
[TBL] [Abstract][Full Text] [Related]
98. Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2010; 55(5-6):199-207. PubMed ID: 20626175
[TBL] [Abstract][Full Text] [Related]
99. Optimal management of low-risk gestational trophoblastic neoplasia.
Goldstein DP; Berkowitz RS; Horowitz NS
Expert Rev Anticancer Ther; 2015; 15(11):1293-304. PubMed ID: 26517533
[TBL] [Abstract][Full Text] [Related]
100. Comparison of the efficacy of methotrexate and actinomycin D in the treatment of patients with stage I low risk gestational trophoblastic neoplasia (GTN).
Shahbazian N; Razi T; Razi S; Yazdanpanah L
Med J Islam Repub Iran; 2014; 28():78. PubMed ID: 25405143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
